nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Abnormal pigmentation—Epirubicin—ovarian cancer	0.0439	0.044	CcSEcCtD
Propericiazine—Abnormal pigmentation—Doxorubicin—ovarian cancer	0.0406	0.0407	CcSEcCtD
Propericiazine—Ileus paralytic—Vinorelbine—ovarian cancer	0.0249	0.0249	CcSEcCtD
Propericiazine—Pigmentation disorder—Paclitaxel—ovarian cancer	0.0217	0.0217	CcSEcCtD
Propericiazine—Hyperpyrexia—Paclitaxel—ovarian cancer	0.0194	0.0195	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—ovarian cancer	0.0182	0.0183	CcSEcCtD
Propericiazine—Deep vein thrombosis—Vinorelbine—ovarian cancer	0.0177	0.0177	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—ovarian cancer	0.0169	0.0169	CcSEcCtD
Propericiazine—Ileus paralytic—Paclitaxel—ovarian cancer	0.0167	0.0168	CcSEcCtD
Propericiazine—Amenorrhoea—Chlorambucil—ovarian cancer	0.0161	0.0161	CcSEcCtD
Propericiazine—Dyskinesia—Chlorambucil—ovarian cancer	0.015	0.0151	CcSEcCtD
Propericiazine—Venous thromboembolism—Epirubicin—ovarian cancer	0.0141	0.0141	CcSEcCtD
Propericiazine—Amenorrhoea—Melphalan—ovarian cancer	0.014	0.014	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—ovarian cancer	0.013	0.013	CcSEcCtD
Propericiazine—Pulmonary embolism—Topotecan—ovarian cancer	0.0126	0.0126	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—ovarian cancer	0.0124	0.0124	CcSEcCtD
Propericiazine—Pigmentation disorder—Doxorubicin—ovarian cancer	0.0115	0.0115	CcSEcCtD
Propericiazine—Menstruation irregular—Docetaxel—ovarian cancer	0.0111	0.0111	CcSEcCtD
Propericiazine—Pulmonary embolism—Vinorelbine—ovarian cancer	0.0108	0.0108	CcSEcCtD
Propericiazine—Deep vein thrombosis—Docetaxel—ovarian cancer	0.0101	0.0101	CcSEcCtD
Propericiazine—Infection—Carboplatin—ovarian cancer	0.00973	0.00975	CcSEcCtD
Propericiazine—Vomiting—Altretamine—ovarian cancer	0.00902	0.00903	CcSEcCtD
Propericiazine—Nausea—Altretamine—ovarian cancer	0.00842	0.00844	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—ovarian cancer	0.0082	0.00821	CcSEcCtD
Propericiazine—Pneumonia—Chlorambucil—ovarian cancer	0.00795	0.00796	CcSEcCtD
Propericiazine—Body temperature increased—Carboplatin—ovarian cancer	0.00775	0.00776	CcSEcCtD
Propericiazine—Jaundice—Chlorambucil—ovarian cancer	0.0077	0.00772	CcSEcCtD
Propericiazine—Dyskinesia—Paclitaxel—ovarian cancer	0.0077	0.00771	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—ovarian cancer	0.00758	0.0076	CcSEcCtD
Propericiazine—Atrioventricular block—Paclitaxel—ovarian cancer	0.00746	0.00747	CcSEcCtD
Propericiazine—Pulmonary embolism—Paclitaxel—ovarian cancer	0.00724	0.00725	CcSEcCtD
Propericiazine—Ventricular tachycardia—Paclitaxel—ovarian cancer	0.00724	0.00725	CcSEcCtD
Propericiazine—Weight increased—Topotecan—ovarian cancer	0.00718	0.00719	CcSEcCtD
Propericiazine—Pneumonia—Topotecan—ovarian cancer	0.00708	0.00709	CcSEcCtD
Propericiazine—Amenorrhoea—Docetaxel—ovarian cancer	0.00698	0.00699	CcSEcCtD
Propericiazine—Jaundice—Melphalan—ovarian cancer	0.00671	0.00673	CcSEcCtD
Propericiazine—Pulmonary embolism—Docetaxel—ovarian cancer	0.00613	0.00614	CcSEcCtD
Propericiazine—Pneumonia—Vinorelbine—ovarian cancer	0.00605	0.00606	CcSEcCtD
Propericiazine—Tremor—Chlorambucil—ovarian cancer	0.00579	0.00579	CcSEcCtD
Propericiazine—Nasal congestion—Paclitaxel—ovarian cancer	0.00577	0.00578	CcSEcCtD
Propericiazine—Agitation—Chlorambucil—ovarian cancer	0.00568	0.00568	CcSEcCtD
Propericiazine—Angioedema—Chlorambucil—ovarian cancer	0.00564	0.00565	CcSEcCtD
Propericiazine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00562	0.00562	CcSEcCtD
Propericiazine—Arrhythmia—Melphalan—ovarian cancer	0.00552	0.00553	CcSEcCtD
Propericiazine—Confusional state—Chlorambucil—ovarian cancer	0.00508	0.00509	CcSEcCtD
Propericiazine—Angioedema—Topotecan—ovarian cancer	0.00502	0.00503	CcSEcCtD
Propericiazine—Cardiac disorder—Vinorelbine—ovarian cancer	0.00501	0.00502	CcSEcCtD
Propericiazine—Infection—Chlorambucil—ovarian cancer	0.00501	0.00502	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—ovarian cancer	0.00492	0.00492	CcSEcCtD
Propericiazine—Arrhythmia—Vinorelbine—ovarian cancer	0.00483	0.00483	CcSEcCtD
Propericiazine—Hypokalaemia—Paclitaxel—ovarian cancer	0.00478	0.00479	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00471	0.00472	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—ovarian cancer	0.00471	0.00472	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—ovarian cancer	0.00455	0.00456	CcSEcCtD
Propericiazine—Infection—Topotecan—ovarian cancer	0.00446	0.00446	CcSEcCtD
Propericiazine—Sweating increased—Paclitaxel—ovarian cancer	0.00442	0.00443	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—ovarian cancer	0.0044	0.00441	CcSEcCtD
Propericiazine—Oedema—Melphalan—ovarian cancer	0.00439	0.0044	CcSEcCtD
Propericiazine—Infection—Melphalan—ovarian cancer	0.00436	0.00437	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—ovarian cancer	0.00436	0.00436	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00436	0.00436	CcSEcCtD
Propericiazine—Hyperhidrosis—Topotecan—ovarian cancer	0.00434	0.00434	CcSEcCtD
Propericiazine—Angioedema—Vinorelbine—ovarian cancer	0.0043	0.0043	CcSEcCtD
Propericiazine—Tachycardia—Melphalan—ovarian cancer	0.00429	0.00429	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—ovarian cancer	0.00426	0.00427	CcSEcCtD
Propericiazine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00414	0.00415	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00414	0.00414	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—ovarian cancer	0.00414	0.00414	CcSEcCtD
Propericiazine—Weight increased—Paclitaxel—ovarian cancer	0.00413	0.00414	CcSEcCtD
Propericiazine—Hypotension—Melphalan—ovarian cancer	0.00411	0.00411	CcSEcCtD
Propericiazine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.0041	0.0041	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—ovarian cancer	0.00407	0.00408	CcSEcCtD
Propericiazine—Pneumonia—Paclitaxel—ovarian cancer	0.00407	0.00408	CcSEcCtD
Propericiazine—Dyspnoea—Topotecan—ovarian cancer	0.004	0.00401	CcSEcCtD
Propericiazine—Body temperature increased—Chlorambucil—ovarian cancer	0.00398	0.00399	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—ovarian cancer	0.00395	0.00395	CcSEcCtD
Propericiazine—Dyspnoea—Melphalan—ovarian cancer	0.00392	0.00392	CcSEcCtD
Propericiazine—Constipation—Topotecan—ovarian cancer	0.00384	0.00384	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00383	0.00383	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—ovarian cancer	0.00383	0.00383	CcSEcCtD
Propericiazine—Infection—Vinorelbine—ovarian cancer	0.00381	0.00382	CcSEcCtD
Propericiazine—Tachycardia—Vinorelbine—ovarian cancer	0.00375	0.00375	CcSEcCtD
Propericiazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00371	0.00372	CcSEcCtD
Propericiazine—Hypotension—Vinorelbine—ovarian cancer	0.00359	0.00359	CcSEcCtD
Propericiazine—Body temperature increased—Topotecan—ovarian cancer	0.00355	0.00355	CcSEcCtD
Propericiazine—Weight increased—Docetaxel—ovarian cancer	0.0035	0.00351	CcSEcCtD
Propericiazine—Pneumonia—Docetaxel—ovarian cancer	0.00345	0.00346	CcSEcCtD
Propericiazine—Diarrhoea—Chlorambucil—ovarian cancer	0.00345	0.00345	CcSEcCtD
Propericiazine—Dyspnoea—Vinorelbine—ovarian cancer	0.00342	0.00343	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—ovarian cancer	0.00342	0.00343	CcSEcCtD
Propericiazine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00337	0.00338	CcSEcCtD
Propericiazine—Jaundice—Docetaxel—ovarian cancer	0.00334	0.00335	CcSEcCtD
Propericiazine—Hypersensitivity—Topotecan—ovarian cancer	0.00331	0.00331	CcSEcCtD
Propericiazine—Constipation—Vinorelbine—ovarian cancer	0.00328	0.00329	CcSEcCtD
Propericiazine—Arrhythmia—Paclitaxel—ovarian cancer	0.00325	0.00325	CcSEcCtD
Propericiazine—Hypersensitivity—Melphalan—ovarian cancer	0.00324	0.00324	CcSEcCtD
Propericiazine—Vomiting—Chlorambucil—ovarian cancer	0.0032	0.00321	CcSEcCtD
Propericiazine—Agranulocytosis—Docetaxel—ovarian cancer	0.0032	0.00321	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—ovarian cancer	0.0032	0.0032	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—ovarian cancer	0.00316	0.00317	CcSEcCtD
Propericiazine—Diarrhoea—Topotecan—ovarian cancer	0.00307	0.00307	CcSEcCtD
Propericiazine—Body temperature increased—Vinorelbine—ovarian cancer	0.00303	0.00304	CcSEcCtD
Propericiazine—Diarrhoea—Melphalan—ovarian cancer	0.00301	0.00301	CcSEcCtD
Propericiazine—Nausea—Chlorambucil—ovarian cancer	0.00299	0.003	CcSEcCtD
Propericiazine—Vision blurred—Paclitaxel—ovarian cancer	0.00298	0.00299	CcSEcCtD
Propericiazine—Tremor—Paclitaxel—ovarian cancer	0.00296	0.00297	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—ovarian cancer	0.00296	0.00296	CcSEcCtD
Propericiazine—Agitation—Paclitaxel—ovarian cancer	0.00291	0.00291	CcSEcCtD
Propericiazine—Angioedema—Paclitaxel—ovarian cancer	0.00289	0.00289	CcSEcCtD
Propericiazine—Cardiac disorder—Docetaxel—ovarian cancer	0.00286	0.00286	CcSEcCtD
Propericiazine—Vomiting—Topotecan—ovarian cancer	0.00285	0.00286	CcSEcCtD
Propericiazine—Rash—Topotecan—ovarian cancer	0.00283	0.00283	CcSEcCtD
Propericiazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00283	0.00283	CcSEcCtD
Propericiazine—Dermatitis—Topotecan—ovarian cancer	0.00283	0.00283	CcSEcCtD
Propericiazine—Vomiting—Melphalan—ovarian cancer	0.00279	0.0028	CcSEcCtD
Propericiazine—Rash—Melphalan—ovarian cancer	0.00277	0.00277	CcSEcCtD
Propericiazine—Dermatitis—Melphalan—ovarian cancer	0.00277	0.00277	CcSEcCtD
Propericiazine—Arrhythmia—Docetaxel—ovarian cancer	0.00275	0.00276	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—ovarian cancer	0.00273	0.00274	CcSEcCtD
Propericiazine—Nausea—Topotecan—ovarian cancer	0.00267	0.00267	CcSEcCtD
Propericiazine—Dry mouth—Paclitaxel—ovarian cancer	0.00263	0.00264	CcSEcCtD
Propericiazine—Diarrhoea—Vinorelbine—ovarian cancer	0.00263	0.00263	CcSEcCtD
Propericiazine—Nausea—Melphalan—ovarian cancer	0.00261	0.00261	CcSEcCtD
Propericiazine—Confusional state—Paclitaxel—ovarian cancer	0.0026	0.00261	CcSEcCtD
Propericiazine—Asthma—Epirubicin—ovarian cancer	0.0026	0.0026	CcSEcCtD
Propericiazine—Oedema—Paclitaxel—ovarian cancer	0.00258	0.00259	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—ovarian cancer	0.00257	0.00257	CcSEcCtD
Propericiazine—Infection—Paclitaxel—ovarian cancer	0.00256	0.00257	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—ovarian cancer	0.00253	0.00253	CcSEcCtD
Propericiazine—Tachycardia—Paclitaxel—ovarian cancer	0.00252	0.00252	CcSEcCtD
Propericiazine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0025	0.0025	CcSEcCtD
Propericiazine—Vomiting—Vinorelbine—ovarian cancer	0.00244	0.00244	CcSEcCtD
Propericiazine—Rash—Vinorelbine—ovarian cancer	0.00242	0.00242	CcSEcCtD
Propericiazine—Dermatitis—Vinorelbine—ovarian cancer	0.00242	0.00242	CcSEcCtD
Propericiazine—Hypotension—Paclitaxel—ovarian cancer	0.00241	0.00242	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—ovarian cancer	0.0024	0.00241	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—ovarian cancer	0.00238	0.00238	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00237	0.00237	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—ovarian cancer	0.00236	0.00237	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—ovarian cancer	0.00234	0.00234	CcSEcCtD
Propericiazine—Insomnia—Paclitaxel—ovarian cancer	0.00233	0.00234	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—ovarian cancer	0.00233	0.00233	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—ovarian cancer	0.00231	0.00232	CcSEcCtD
Propericiazine—Dyspnoea—Paclitaxel—ovarian cancer	0.0023	0.00231	CcSEcCtD
Propericiazine—Somnolence—Paclitaxel—ovarian cancer	0.0023	0.0023	CcSEcCtD
Propericiazine—Nausea—Vinorelbine—ovarian cancer	0.00228	0.00228	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—ovarian cancer	0.00226	0.00226	CcSEcCtD
Propericiazine—Dry mouth—Docetaxel—ovarian cancer	0.00223	0.00224	CcSEcCtD
Propericiazine—Constipation—Paclitaxel—ovarian cancer	0.00221	0.00221	CcSEcCtD
Propericiazine—Confusional state—Docetaxel—ovarian cancer	0.00221	0.00221	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00219	0.0022	CcSEcCtD
Propericiazine—Oedema—Docetaxel—ovarian cancer	0.00219	0.00219	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—ovarian cancer	0.00219	0.00219	CcSEcCtD
Propericiazine—Infection—Docetaxel—ovarian cancer	0.00217	0.00218	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00217	0.00217	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—ovarian cancer	0.00216	0.00216	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—ovarian cancer	0.00215	0.00216	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—ovarian cancer	0.00214	0.00214	CcSEcCtD
Propericiazine—Tachycardia—Docetaxel—ovarian cancer	0.00214	0.00214	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—ovarian cancer	0.00209	0.00209	CcSEcCtD
Propericiazine—Hypotension—Docetaxel—ovarian cancer	0.00204	0.00205	CcSEcCtD
Propericiazine—Body temperature increased—Paclitaxel—ovarian cancer	0.00204	0.00204	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.002	0.002	CcSEcCtD
Propericiazine—Insomnia—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Propericiazine—Dyspnoea—Docetaxel—ovarian cancer	0.00195	0.00195	CcSEcCtD
Propericiazine—Somnolence—Docetaxel—ovarian cancer	0.00195	0.00195	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—ovarian cancer	0.00193	0.00193	CcSEcCtD
Propericiazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.0019	0.00191	CcSEcCtD
Propericiazine—Constipation—Docetaxel—ovarian cancer	0.00187	0.00187	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—ovarian cancer	0.00186	0.00186	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00178	0.00179	CcSEcCtD
Propericiazine—Diarrhoea—Paclitaxel—ovarian cancer	0.00177	0.00177	CcSEcCtD
Propericiazine—Body temperature increased—Docetaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—ovarian cancer	0.0017	0.00171	CcSEcCtD
Propericiazine—Agitation—Epirubicin—ovarian cancer	0.00166	0.00166	CcSEcCtD
Propericiazine—Vomiting—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Propericiazine—Rash—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Propericiazine—Dermatitis—Paclitaxel—ovarian cancer	0.00163	0.00163	CcSEcCtD
Propericiazine—Hypersensitivity—Docetaxel—ovarian cancer	0.00161	0.00161	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Propericiazine—Nausea—Paclitaxel—ovarian cancer	0.00153	0.00154	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Propericiazine—Diarrhoea—Docetaxel—ovarian cancer	0.0015	0.0015	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Propericiazine—Oedema—Epirubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Propericiazine—Infection—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—ovarian cancer	0.00139	0.0014	CcSEcCtD
Propericiazine—Vomiting—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Propericiazine—Rash—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Propericiazine—Dermatitis—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—ovarian cancer	0.00137	0.00137	CcSEcCtD
Propericiazine—Infection—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—ovarian cancer	0.00133	0.00134	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Propericiazine—Nausea—Docetaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Propericiazine—Constipation—Epirubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—ovarian cancer	0.00121	0.00122	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—ovarian cancer	0.000938	0.00094	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—ovarian cancer	0.000934	0.000936	CcSEcCtD
Propericiazine—Rash—Epirubicin—ovarian cancer	0.000931	0.000932	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—ovarian cancer	0.00093	0.000931	CcSEcCtD
Propericiazine—Nausea—Epirubicin—ovarian cancer	0.000877	0.000878	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—ovarian cancer	0.000868	0.00087	CcSEcCtD
Propericiazine—Rash—Doxorubicin—ovarian cancer	0.000861	0.000862	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—ovarian cancer	0.00086	0.000862	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—ovarian cancer	0.000811	0.000812	CcSEcCtD
Propericiazine—Domperidone—ABCB1—ovarian cancer	0.000327	0.205	CrCbGaD
Propericiazine—Triflupromazine—ABCB1—ovarian cancer	0.000264	0.166	CrCbGaD
Propericiazine—Fluphenazine—ABCB1—ovarian cancer	0.000203	0.128	CrCbGaD
Propericiazine—Clomipramine—ABCB1—ovarian cancer	0.000186	0.117	CrCbGaD
Propericiazine—Promethazine—ABCB1—ovarian cancer	0.000165	0.103	CrCbGaD
Propericiazine—Trifluoperazine—ABCB1—ovarian cancer	0.000163	0.102	CrCbGaD
Propericiazine—Quetiapine—ABCB1—ovarian cancer	0.000158	0.099	CrCbGaD
Propericiazine—Chlorpromazine—ABCB1—ovarian cancer	0.000128	0.0801	CrCbGaD
